Cerebral Infarction: A Risk after Bacterial Meningitis

Published Online: Sunday, January 29, 2012
A recent study conducted at the University of Amsterdam has found that cerebral infarction is a serious concern in adults who contract community-acquired bacterial meningitis. They indicate that steps taken to prevent cerebral infarction would decrease morbidity and mortality.

Approximately 80% to 85% of all bacterial meningitis is caused by Streptococcus pneumoniae or Neisseria meningitides; morbidity is 30% and 10%, respectively. Cerebrovascular complications are especially common in patients who have pneumoccal meningitis, with up to 29% affected.

These researchers looked at 696 patients, 25% of whom experienced a cerebral infarction pursuant to meningitis.  They identified several factors that increase the likelihood of cerebral infarction: older age, low level of consciousness, systemic inflammation, and infection with S. pneumonia.

More work is needed to determine if drug therapies can be used adjunctively to prevent cerebral infarction. 

Latest Articles
Skipping a flu shot may put patients at greater risk for flu-related pneumonia.
This weekly video program highlights the latest in pharmacy news, product news, and more.
Mylan has launched a generic version of Teva Pharmaceuticals’ Adderall in 5 mg, 7.5 mg, 10 mg, 12.5 mg, 20 mg, and 30 mg doses.
The FDA has approved Boehringer Ingelheim’s oral direct thrombin inhibitor dabigatran etexilate mesylate (Pradaxa) for the prophylaxis of deep vein thrombosis and pulmonary embolism in patients who have had hip replacement surgery.
Latest Issues